DESANTIS, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 368
EU - Europa 198
AS - Asia 42
AF - Africa 7
OC - Oceania 3
SA - Sud America 3
Totale 621
Nazione #
US - Stati Uniti d'America 365
IT - Italia 122
FR - Francia 19
DE - Germania 16
VN - Vietnam 13
EG - Egitto 7
GB - Regno Unito 7
KR - Corea 6
SE - Svezia 6
IN - India 5
JP - Giappone 5
CN - Cina 4
CZ - Repubblica Ceca 4
UA - Ucraina 4
FI - Finlandia 3
IL - Israele 3
NL - Olanda 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
CA - Canada 2
GR - Grecia 2
HR - Croazia 2
IE - Irlanda 2
PE - Perù 2
RS - Serbia 2
AR - Argentina 1
AT - Austria 1
ES - Italia 1
IR - Iran 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 621
Città #
Bari 33
Ashburn 32
Woodbridge 23
Houston 22
Fairfield 20
Dong Ket 13
Seattle 11
Taranto 11
Wilmington 9
Ann Arbor 8
Dokki 7
Los Angeles 7
Cambridge 6
Davoli 6
Naples 6
Rome 6
Buffalo 5
Chicago 5
Milan 5
New York 5
Nuremberg 5
Suwanee 5
Altamura 4
Boardman 4
Bruehl 4
Henderson 4
Monopoli 4
Mottola 4
Nashville 4
Ahmedabad 3
Bisceglie 3
Boydton 3
Columbus 3
Helsinki 3
Karachi 3
Lecce 3
Linköping 3
San Diego 3
Stockholm 3
Turin 3
Berlin 2
Birmingham 2
Bolzano 2
Brussels 2
Canicattì 2
Caselle Torinese 2
Catania 2
Dallas 2
Genoa 2
Giv‘at Shmuel 2
Lima 2
London 2
Matsudo 2
Oak Park 2
Osaka 2
Paris 2
Provo 2
San Francisco 2
San Jose 2
Seoul 2
Shrewsbury 2
Songpa-gu 2
Tullamore 2
Varese 2
Zagreb 2
Arzano 1
Athens 1
Auckland 1
Bengaluru 1
Bologna 1
Bonnyrigg 1
College Station 1
Council Bluffs 1
Denver 1
Des Moines 1
Grafing 1
Gravina in Puglia 1
Hamilton 1
Hangzhou 1
Hanover 1
Highett 1
Imbersago 1
Incheon 1
Indianapolis 1
Krasnoobsk 1
Lake Forest 1
León 1
Lodz 1
Lombard 1
Madrid 1
Mascalucia 1
Miami 1
Morgantown 1
New Orleans 1
Norwalk 1
Novara 1
Padova 1
Perugia 1
Pune 1
Rimini 1
Totale 396
Nome #
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma, file dd9e0c69-57a7-1e9c-e053-3a05fe0a45ef 97
The role of SIRT6 in tumors, file dd9e0c64-c830-1e9c-e053-3a05fe0a45ef 93
Microenvironment drug resistance in multiple myeloma: Emerging new players, file dd9e0c63-e4bd-1e9c-e053-3a05fe0a45ef 80
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?, file dd9e0c65-76fa-1e9c-e053-3a05fe0a45ef 73
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma, file dd9e0c65-4f63-1e9c-e053-3a05fe0a45ef 69
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma, file dd9e0c65-61a9-1e9c-e053-3a05fe0a45ef 54
FGF trapping inhibits multiple myeloma growth through c-Myc degradation–induced mitochondrial oxidative stress, file dd9e0c6b-5a00-1e9c-e053-3a05fe0a45ef 41
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study, file dd9e0c65-15b3-1e9c-e053-3a05fe0a45ef 35
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment, file dd9e0c65-b63f-1e9c-e053-3a05fe0a45ef 35
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes, file dd9e0c65-819e-1e9c-e053-3a05fe0a45ef 12
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance”, file dd9e0c64-dd88-1e9c-e053-3a05fe0a45ef 11
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients., file dd9e0c64-c20e-1e9c-e053-3a05fe0a45ef 8
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus, file dd9e0c65-5cb1-1e9c-e053-3a05fe0a45ef 4
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients, file dd9e0c66-e512-1e9c-e053-3a05fe0a45ef 4
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease, file dd9e0c6b-41ce-1e9c-e053-3a05fe0a45ef 3
Antiangiogenic drugs as chemosensitizers in hematological tumors, file dd9e0c6b-c7bf-1e9c-e053-3a05fe0a45ef 3
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities, file dd9e0c6c-4af7-1e9c-e053-3a05fe0a45ef 3
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance, file 1a8cf391-f777-495e-9498-e59e78c8d6e4 2
Erratum: Corrigendum to “Isolation and characterization of neural stem cells from dystrophic mdx mouse” (Experimental Cell Research (2016) 343(1) (190–207) (S0014482716300593) (10.1016/j.yexcr.2016.03.019)), file dd9e0c63-e4bf-1e9c-e053-3a05fe0a45ef 2
Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis, file 3d8fca09-2545-4d2d-a566-669f604c2298 1
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS, file 5049c8c1-b655-4b87-95f1-45f4b6c4d025 1
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value, file 69eecfa9-33d3-47ed-b28b-c4fb3cf1a097 1
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance”, file dd9e0c64-d486-1e9c-e053-3a05fe0a45ef 1
Isolation and characterization of neural stem cells from dystrophic mdx mouse, file dd9e0c65-453a-1e9c-e053-3a05fe0a45ef 1
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma, file dd9e0c65-5d00-1e9c-e053-3a05fe0a45ef 1
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro, file dd9e0c67-2a50-1e9c-e053-3a05fe0a45ef 1
Totale 636
Categoria #
all - tutte 2.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/20201 1 0 0 0 0 0 0 0 0 0 0 0
2020/2021118 0 0 0 0 8 8 14 19 7 28 10 24
2021/2022161 6 0 7 11 23 7 7 4 8 8 60 20
2022/2023229 14 8 48 38 22 14 14 25 2 16 25 3
2023/2024118 3 11 15 11 14 13 17 14 10 10 0 0
Totale 636